Bethesda, MD (January 20,2022) – AGA and Varia Ventures have launched a new fund to invest in fast-growing, early-stage companies in the GI space. The fund will speed innovations from concept to clinic for the benefit of patients with digestive disease.
GI innovators often face a funding gap at the earliest stages of development; strategic investments of $250K to $2M could make their idea successful – but most venture capital (VC) firms do not fund such early-stage innovation. The GI Opportunity Fund seeks to fill that gap by connecting GI innovators with GI investors.